Home > Insider Trading > Filing (0000899243-23-015663)

Filing Details

Accession Number:: 0000899243-23-015663
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-06-15 21:00:11
Reporting Period:: 2023-06-13

Accepted Time:: 2023-06-15 21:00:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1706431	Vir Biotechnology Inc.	VIR	Biological Products, (No Disgnostic Substances) (2836)	812730369

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1731509	Ltd (Uk) Advisers Investment Sb	69 Grosvenor Street London X0 W1K 3JP	No	No	Yes	No
1755143	L.p. M1) (Aiv Fund Vision Softbank	251 Little Falls Drive Wilmington DE 19808	No	No	Yes	No
1782338	Ltd (Cayman) Endurance Svf	C/O Walkers Corp Ltd., 190 Elgin Avenue George Town E9 KY1-9008	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-06-13	36,547	$26.81	17,102,476	No	4	S	Indirect	See footnote
Common Stock	Disposition	2023-06-13	70,307	$27.23	17,032,169	No	4	S	Indirect	See footnote
Common Stock	Disposition	2023-06-14	20,967	$25.92	17,011,202	No	4	S	Indirect	See footnote
Common Stock	Disposition	2023-06-14	36,281	$26.24	16,974,921	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.6169 to $26.9997. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. ("SVF"). SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed as alternative investment fund manager ("AIFM") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.49. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.77 to $25.9999. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.6587. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.